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Nickel compounds are carcinogenic to humans, possibly through induction of reactive oxygen species
(ROS) that damage macromolecules including DNA and proteins. The aim of the present study is to
elucidate the role of the ROS-mediated Akt/apoptosis-regulating signal kinase (ASK) 1/p38 pathway in
nickel-induced apoptosis. Exposure of human bronchial epithelial cells (BEAS-2B) to nickel compounds
induced the generation of ROS and activation of Akt that is associated with the activation of ASK1 and
p38 mitogen-activated protein kinase. Immunoblotting suggested a down-regulation of several antiapoptotic
proteins, including Bcl-2 and Bcl-xL in the nickel compound-treated cells. Indeed, a notable cell apoptosis
following nickel compound treatment is evident as revealed by ﬂow cytometry analysis. N-Acetyl-L-
cysteine (NAC, a general antioxidant) and vitamin E or catalase (a speciﬁc H2O2 inhibitor) all decreased
nickel-induced ROS generation. Scavenging of nickel-induced ROS by NAC or catalase attenuated Akt,
ASK1, and p38 MAPK activation and apoptosis, which implies involvement of ROS in the Akt/ASK1/
p38 pathway. In addition, nickel-induced activation of p38 MAPK was attenuated by a small interference
of RNA speciﬁc to ASK1 (siRNA ASK1), implying that p38 MAPK was downstream of ASK1, while
ASK1 activation was not reversely regulated by the inhibition of p38 MAPK by SB203580, a widely
used p38 MAPK inhibitor. Silencing Akt by siRNA reduced the activation of ASK1 and p38 MAPK and
cell apoptosis, whereas without nickel stimulation, siRNA Akt had no effect on the activation of ASK1
and p38 MAPK. Thus, these results suggest that the ROS-dependent Akt-ASK1-p38 axis is important
for nickel-induced apoptosis.
Introduction
Nickel is a toxic transition metal and is widely used in many
industries, including electroplating and the manufacture of steel,
some special alloys, batteries, and electronic devices. Epide-
miological studies have indicated that chronic occupational
exposure to nickel (Ni) compounds increases the incidence of
certain human cancers, such as lung and nasal cancers (1, 2).
Nickel exposure-induced generation of reactive oxygen species
(ROS) has been considered a pivotal step in nickel-induced
carcinogenesis (3). Recent studies also show that ROS produc-
tion induced by nickel exposure is involved in nickel-induced
apoptosis (4, 5). Apoptosis is originally viewed as a normal
physiologic process, removing cells carrying abnormal genetic
information to maintain the functional integrity of the cell
populations. In the case of metal-induced apoptosis, in contrast,
it might allow the escape of cells with potentially carcinogenic
ability from apoptosis under certain conditions, due to an
abnormal apoptotic response (6). Therefore, investigation of
nickel-induced apoptosis is necessary to understand the overall
mechanism of nickel-induced carcinogenesis. One of the pos-
sible mechanisms of nickel-induced apoptosis and carcinogen-
esis is the induction of ROS by nickel compounds.
ROS, such as superoxide anion (O2
•-), hydrogen peroxide
(H2O2), and the hydroxyl radical (HO•), have numerous effects
on essential biological processes, including normal cell growth,
induction and maintenance of the transformed state, programmed
cell death, and cellular senescence (7). An aberrant increase in
the level of ROS may result in transient or permanent cellular
alterations, such as irreversible oxidative damage on DNA,
causing genomic instability and the consequent malignant
transformation of the cells (8). Thus, ROS are thought to play
multiple roles in tumor initiation, progression, and maintenance.
Various studies have demonstrated that ROS induced by toxic
metals are critical in metal-induced apoptosis and carcinogenesis
(4, 6, 9).
ROS generation has been shown to be involved in the Akt
(protein kinase B) signaling pathway (10, 11). Akt serine/
threonine kinases are one of the essential regulators of cell
survival function in response to growth factor stimulations
(12, 13). It is generally believed that Akt kinases are antiapo-
ptotic through phosphorylation and inhibition of a number of
apoptosis regulatory proteins (14). Apoptosis signal-regulating
kinase 1 (ASK1) has been reported to be phosphorylated by
Akt at serine 83 (Ser83) and its activity reduced (15-17). ASK1
is a serine-threonine kinase that was initially discovered as a
mitogen-activated protein kinase kinase kinase (MAPKKK) in
the c-Jun N-terminal kinase/stress-activated protein kinase (JNK/
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Published on Web 01/29/2010SAPK) and p38 MAPK signaling cascades (18, 19). A variety
of stress-related stimuli activate ASK1. These stimuli include
serum or trophic factor withdrawal, TNF-R, ROS, microtubule-
interfering agents, and genotoxic stress. Some of these stress
signals induce Thr838 (corresponding to Thr845 in mice)
phosphorylation and activation of the ASK1 (20, 21). Activated
ASK1 will result in activation of the downstream kinases,
leading to cell apoptosis (18, 19, 22).
To date, the majority of research on Akt has focused on its
role in cell growth promotion. Little is known about its function
in cell apoptosis. The present study demonstrates that nickel-
induced generation of ROS activated Akt, which activated ASK1
through Thr838 phosphorylation, leading to downstream activa-
tion of p38 MAPK, eventually causing cell apoptosis.
Materials and Methods
Cell Culture and Other Reagents. Human bronchial epithelial
cells cells (BEAS-2B) were cultured in Dulbecco’s modiﬁed Eagle’s
medium (DMEM, Calbiochem) supplemented with 10% fetal
bovine serum (FBS), 5% penicillin/streptomycin, and 2 mM
L-glutamine (Invitrogen) at 37 °C in a humidiﬁed atmosphere with
5% CO2. Nickel subsulﬁde (Ni3S2), N-acetyl-L-cysteine (NAC), and
vitamin E (R-tocopherol) were purchased from Sigma; catalase was
from Roche Applied Science Co. Dihydroethidium (DHE) and
5-(and-6)-chloromethyl-2′,7 ′-dichlorodihydroﬂuorescein diacetate
acetyl ester (CM-H2DCFDA) were from Invitrogen (Eugene, OR).
Antibodies against Akt, phospho-JNK, JNK, and  -actin were
purchased from Santa Cruz Biotechnology. Bcl-xL, phospho-Akt
speciﬁc for Ser473 phosphorylation, phospho-ASK1 speciﬁc for
Thr838 phosphorylation, phospho-ASK1 speciﬁc for Ser83 phos-
phorylation, ASK1, phospho-p38, and p38 were purchased from
Cell Signaling. Bcl-2 was purchased from DAKO, anticatalase
antibody was from Novus Biologicals, Inc., and anti-Cu/Zn SOD
and anti-MnSOD antibody were from Upstate Biotechnology. All
primary antibodies were diluted at 1:1000, except 1:2000 for actin
and 1:200 for phospho-p38, and secondary antibodies were diluted
at 1:4000.
Determination of ROS Production. ROS were detected by
staining the cells with DHE or CM-H2DCFDA (Molecular Probes).
DHE is oxidized to red ﬂuorescent ethidium by O2
•-, and CM-
H2DCFDA is oxidized to green ﬂuorescent DCF (dichloroﬂuores-
cein) by H2O2 (23). Cells were loaded with 10 µM DHE and 5 µM
CM-H2DCFDA for 30 min, respectively, at 37 °C, and 5% CO2 in
PBS and then were washed with PBS and returned to media for a
30 min recovery period. The mean ﬂuorescence intensity was
determined as ROS generation by ﬂow cytometry FACS Calibur
(BD Bioscience, San Jose, CA). Quantitative assay of ROS
generation was performed by normalization to the control group.
Cell Counting Assay. Cell counting was performed to assess
the inhibitory effect of Ni3S2 on cell proliferation. BEAS-2B cells
were seeded in each well of six well plates overnight and then
treated without or with various doses of Ni3S2 for 72 h or with
Ni3S2 2 µg/cm2 for various time points as indicated. After
treatments, cells were washed by PBS and trypsinized, and then,
cell counting was carried out using BECKMAN COULTER.
Annexin V/Propidium Iodide Assays for Apoptosis. For
Annexin V/propidium iodide (PI) assays, BEAS-2B cells were
stained with Annexin V-FITC and PI and then evaluated for
apoptosis by ﬂow cytometry according to the manufacturer’s
protocol (BD Pharmingen). Brieﬂy, 1 × 106 cells were washed twice
with cold PBS and stained with 5 µL of Annexin V-FITC and 8
µLo fP I( 5µg/mL) in 1 × binding buffer [10 mmol/L HEPES
(pH 7.4), 140 mmol/L NaOH, and 2.5 mmol/L CaCl2] for 10 min
at room temperature in the dark. The apoptotic cells were
determined using a Becton Dickinson FACScan cytoﬂuorometer.
Both early apoptotic (Annexin V-positive and PI-negative) and late
apoptotic (Annexin V-positive and PI-positive) cells were included
in cell death determinations.
Western Blot Assay. Western blot analysis was performed using
the NuPAGE Bis-Tris electrophoresis system (Invitrogen). The total
cellular samples were washed once with ice cold PBS and lysed in
1 × RIPA buffer supplemented with 50 mmol/L DTT (Fisher
Biotech) and then loaded with NuPAGE LDS sample buffer. The
protein concentration was determined using Coomassie Protein
Assay Reagent (Pierce). The total cellular protein extracts were
separated by SDS-PAGE and transferred to nitrocellulose membrane
in 20 mmol/L Tris-HCl (pH 8.0) containing 150 mmol/L glycine
and 20% (v/v) methanol. Membranes were blocked with 5% fat-
free dry milk in 1 × TBS containing 0.05% Tween 20 and incubated
with antibodies. Protein bands were detected by incubation with
horseradish peroxidase-conjugated antibodies (Kirkegaard and Perry
Laboratories) and visualized with enhanced chemiluminescence
reagent (Perkin-Elmer Life Sciences). Band densities in the Western
blots were all analyzed with AlphaImager HP (Alpha Innotech).
Cell Transfection. The control and speciﬁc small interference
RNA targeting ASK1 (siRNA ASK1, which inhibits expression of
ASK1) was purchased from Santa Cruz Co. siRNA Akt (which
inhibits expression of Akt1 and 2, not Akt3) and corresponding
siRNA control were purchased from Cell Signaling Co. To block
ASK1 or Akt signal, cells were transfected with the indicated
siRNA, respectively, using Lipofectamine RNAiMAX from Invit-
rogen Co. The transfection procedure was followed by the protocol
provided by the transfection reagent manufacturer. Brieﬂy, control
siRNA and siRNA ASK1 or Akt were incubated with Lipofectamine
RNAiMAX in OPTI-MEM I for 30 min at room temperature and
then added to cells in maintenance media without antibiotics (the
ﬁnal concentration of both control siRNA and ASK1 or Akt siRNA
was 100 nM each). Media were replaced with maintenance media
with antibiotics 24 h later after transfection, and then, nickel was
added to the media. Experiments were performed approximately
72 h following transfection.
Statistical Analysis. For analysis of apoptosis and cell counting,
values were presented as mean ( SEs. Statistical differences
between controls and treated groups were determined by one-way
ANOVA. Differences were considered statistically signiﬁcant for
P < 0.05.
Results
Nickel Exposure Induces Apoptosis in BEAS-2B Cells.
BEAS-2B cells were treated with Ni3S2 for 48 h followed by
cell apoptosis analyses using ﬂow cytometry. Cell apoptosis was
increased by 11.1, 14.7, and 29.5% at the concentrations of 1,
2, and 4 µg/cm2 of Ni3S2 treatment, respectively, whereas only
4.8% of the control cells were apoptotic (Figure 1A,B). Figure
1C shows that the cell number was also decreased with increased
nickel concentration and treatment time, suggesting that cell
growth arrest was also induced by nickel treatment. Other studies
have shown the inhibitory effect of nickel on cell proliferation
through interfering cell cycle progression. Ding et al. have
demonstrated that up-regulation of cyclin B1 is responsible for
nickel-induced M phase arrest and cell growth inhibition (24).
Others revealed that soluble nickel compounds caused cell
growth arrest and cyclin D1 degradation throught IKK R-de-
pendent pathway (25). Figure 1D shows that nickel treatment,
in addition to decreasing cell number, also induced concomitant
morphological changes of the BEAS-2B cells. The majority of
nickel-treated BEAS-2B cells that originally had an epithelial
cell-like appearance became elongated and resembled ﬁbroblasts
(Figure 1D), as observed and reported by others (26). The
elongation developed in the ﬁrst 24 h of nickel exposure and
persisted throughout the remaining 48 h of treatment.
Bcl-2-family proteins are evolutionarily conserved regulators
of apoptosis (27, 28). Within this family, Bc1-2 and Bcl-xL
proteins are potent antiapoptotic proteins that inhibit a mito-
chondria-operated pathway of apoptosis in many types of cells.
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(Figure 1E,F).
Generation of ROS Stimulated by Nickel Is Required
for Nickel-Induced Apoptosis. It has been reported that nickel
may induce ROS generation of the cells under some circum-
stances (29-31). To study the relationship between ROS
generation and apoptosis, nickel-induced ROS production was
determined by staining the cells with CM-H2DCFDA and DHE,
ﬂuorescent dyes for H2O2 and O2
•-, respectively. Figure 2A
shows that cells treated with Ni3S2 stimulated generation of
H2O2, whereas there was no apparent alteration in O2
•-
generation (Figure 2B). Pretreatment of the cells with antioxidant
NAC decreased H2O2 production (Figure 2C). The addition of
catalase, a scavenger of H2O2, also inhibited ROS generation
(Figure 2D). Vitamin E, another well-established antioxidant,
was also used to evaluate effect on ROS generation stimulated
by nickel. As shown in Figure 2E, pretreatment of BEAS-2B
cells with vitamin E reduced nickel-induced ROS generation.
To investigate the possible role of ROS in nickel-induced
apoptosis, the effects of speciﬁc modiﬁers of ROS on apoptosis
were determined. The results show that pretreatment of the cells
with NAC attenuated nickel-induced apoptosis (p < 0.05) (Figure
2F). We also pretreated BEAS-2B cells with antioxidant vitamin
E, and our result shows that apoptosis induced by nickel was
Figure 1. Nickel induces apoptosis. (A) BEAS-2B cells (4 × 105) were seeded in a 60 mm dish overnight, then treated without or with various
concentrations of Ni3S2 for 48 h, and then stained with Annexin V/PI. Apoptosis was determined using ﬂow cytometry as described in the Materials
and Methods. Illustrated is a representative of at least three separate experiments. (B) Quantiﬁcation of apoptotic cells. Data were obtained from
Annexin V/PI assays and are represented as means ( SEs of three separate experiments. *P < 0.05 as determined by the treatment vs control. (C)
BEAS-2B cells (1.5 × 105) were seeded in each well of six well plates overnight and then treated without or with various doses of Ni3S2 for 72 h
or with 2 µg/cm2 Ni3S2 for various time points as indicated, and then, cell counting was carried out. Data represent means ( SEs of three individual
experiments of cell counting. *P < 0.05 as determined by the treatment vs control. (D) Nickel induces morphological changes in BEAS-2B cells.
BEAS-2B cells were seeded in 60 mm dishes. After they were cultured at 37 °C overnight, the cells were treated without or with 2 µg/cm2 Ni3S2
for 48 h. Pictures were taken using a phase contrast microscope. (E) Down-regulation of Bcl-2 and Bcl-xL is involved in nickel-induced apoptosis.
BEAS-2B cells were seeded in each 100 mm dish and cultured in 10% FBS/DMEM at 37 °C. When the cell density reached 70-80%, the cells
were exposed to different concentrations of Ni3S2 for 48 h. After treatments, total cellular extracts were prepared and subjected to Western blot
assay using antibodies against Bcl-2, Bcl-xL, and  -actin. Each lane was loaded with 40 µg of protein. Blots were subsequently stripped and
reprobed with antibody against  -actin to ensure equivalent loading and transfer. The results shown are representative of three separate experiments.
Two additional studies yielded equivalent results. (F) Band densities in the Western blots were normalized against  -actin. Each bar represents the
mean ( SE of the three independent experiments. All means marked with * (P < 0.05) are signiﬁcantly different from the control.
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addition, the protein level of catalase was decreased with the
stimulation of Ni3S2, while the protein level of Cu/Zn SOD
(SOD1) and Mn SOD (SOD2) remained the same (Figure 2G).
Accordingly, H2O2 is likely the main ROS induced by nickel
treatment.
Signaling Pathway of ASK1/p38 MAPK Is Involved in
Nickel-Induced Apoptosis. Since its discovery by Ichijo et al.
in 1997 (19), ASK1 has drawn much attention in cell apoptosis,
especially in oxidative stress-induced cell apoptosis through
Thr838 (corresponding to Thr845 in mice) phosphorylation
(20, 21). Since nickel induced ROS generation, we speculated
that ASK1 could be involved in nickel-induced apoptosis. By
performing immunoblotting analysis, our results showed that
ASK1 phosphorylation at Thr838, which is correlated with its
activity, was increased with the nickel treatment (Figure 3A),
whereas phosphorylation at Ser83, which attenuates its activity
and promotes cell survival (15), remained unchangeable (Figure
3A). Since ASK1 is located upstream of the SEK1/MKK4-JNK/
SAPK and MKK3/MKK6-p38 pathways (19), we examined the
activation of the multiple downstream protein kinases by
Western blot using phospho-speciﬁc antibodies (JNK and p38).
Figure 3B shows that treatment with nickel resulted in the
activation of p38 MAPK but not JNK.
To investigate the role of ASK1 in regulating p38 MAPK,
we used siRNA that speciﬁcally silences ASK1, an approach
of loss-of-function analysis utilizing RNA interference. Expres-
sion of siRNAs is able to silence gene expression and allows
the functional inactivation of the targeted gene (32, 33). Both
siRNA control and siRNA ASK1 products that we used here
are from Santa Cruz Co. and have been tested to reduce protein
expression in human cells. By Western blotting analysis, our
Figure 2. Oxidative stress is involved in nickel-induced apoptosis. (A, B) Nickel mainly induces H2O2 generation, not O2
•-. BEAS-2B (4 × 105)
cells were seeded in a 60 mm dish overnight and then treated without or with different concentrations of Ni3S2 for 48 h. The cells were labeled with
CM-H2DCFDA and DHE, respectively, followed by ﬂow cytometry as described in the Materials and Methods. The rightward shift of the overlay
reﬂected the ROS generation. Illustrated overlays are representatives of at least three separate experiments. Quantiﬁcations of both H2O2 and O2
•-
generation are displayed on the right panel. Each bar represents the mean ( SE of the three independent experiments. *P < 0.05 as determined by
the treatment vs control. (C, D) NAC and catalase inhibited nickel-induced ROS generation. BEAS-2B cells (4 × 105) were seeded in a 60 mm dish
overnight and then pretreated with or without NAC (10 mM) or catalase (2000 units) for 2 h, respectively, and then treated without or with 2
µg/cm2 Ni3S2 for 48 h. The cells were stained with CM-H2DCFDA and measured by ﬂow cytometry. Overlays shown here are representatives of
at least three separate experiments. Quantiﬁcations of H2O2 generation are displayed on the right panel. Each bar represents the mean ( SE of the
three independent experiments. *P < 0.05 between the indicated two groups. (E) Vitamin E ameliorated nickel-induced ROS generation. BEAS-2B
cells (4 × 105) were seeded in a 60 mm dish overnight and then pretreated with or without vitamin E (20 µM) for 2 h and then treated without or
with 2 µg/cm2 Ni3S2 for 48 h. The cells were stained with CM-H2DCFDA and measured by ﬂow cytometry. The overlay shown here is representative
of at least three separate experiments. Quantiﬁcations of H2O2 generation are displayed on the right panel. Each bar represents the mean ( SE of
the three independent experiments. *P < 0.05 between the indicated two groups. (F) NAC attenuated nickel-induced apoptosis. BEAS-2B cells (4
× 105) were seeded in a 60 mm dish overnight, then pretreated with or without NAC (10 mM) for 2 h, and then treated without or with 4 µg/cm2
Ni3S2 for 48 h. The cells were stained with Annexin V/PI, and apoptosis was determined using ﬂow cytometry as described in the Materials and
Methods. The results shown are the means of triplicate determinations ( SE. *P < 0.05 as determined by the indicated two groups. (G) Nickel
decreased the protein expression of catalase, not Cu/Zn SOD or Mn SOD. BEAS-2B cells were treated without or with various concentrations of
Ni3S2 for 48 h as indicated and then measured by Western blot assay. Four more additional experiments achieved equivalent results. Band densities
of catalase in the Western blots were normalized against  -actin (shown on right panel). Each bar represents the mean ( SE of the three independent
experiments. All means marked with * (P < 0.05) are signiﬁcantly different from the control.
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with siRNA speciﬁc to ASK1 (Figure 3C). We then examined
the effect of siRNA ASK1 on p38 MAPK. Figure 3C shows
that siRNA ASK1 decreased nickel-induced activation of p38
MAPK, suggesting that ASK1 mediated nickel-induced p38
MAPK activation. Utilizing a pharmacological inhibition method,
we checked the effect of p38 MAPK inhibition through
SB203580, a widely used p38 inhibitor, on ASK1 activation,
to see whether ASK1 activation is inversely regulated by p38
MAPK. Immunoblot results show that activation of ASK1
induced by nickel was not altered by SB203580 (Figure 3D).
Akt Kinase Is Activated and Involved in ASK1/p38
MAPK Signaling Pathway in Nickel-Induced Apoptosis. Akt
has been revealed by many researches to play an essential role
in promoting cell survival, inhibiting apoptosis, and so on. By
immunoblotting, we observed a pronounced activation of Akt
by nickel treatment (Figure 4A). It has been reported that Akt
can phosphorylate ASK1 on Ser83 and inactivates the apoptotic
Figure 3. ASK1/p38 MAPK pathway is activated in nickel-induced apoptosis. (A) Nickel treatment increased protein phosphorylation of ASK1 at
Thr838, not Ser83. BEAS-2B cells were treated without or with different concentrations of Ni3S2 for 48 h. After treatments, a Western blot assay
was performed using antibodies against ASK1 at Thr838 or Ser83, respectively. Each lane was loaded with 40 µg of protein. Blots were subsequently
stripped and reprobed with antibody against ΑSK1 to ensure equivalent loading and transfer. The results shown are representative of three separate
experiments. Two additional studies yielded equivalent results. Band densities of ASK1 phosphorylation at Thr838 in the Western blots were
normalized against ASK1 (shown on lower panel). Each bar represents the mean ( SE of the three independent experiments. All means marked
with * (P < 0.05) are signiﬁcantly different from the control. (B) Nickel treatment increased protein phosphorylation of p38, not JNK. BEAS-2B
cells were treated without or with different concentrations of Ni3S2 for 48 h. After treatments, a Western blot assay was performed using antibodies
against phosphor-p38 or phosphor-JNK, respectively. Each lane was loaded with 40 µg of protein. Blots were subsequently stripped and reprobed
with antibody against p38 or JNK to ensure equivalent loading and transfer. The results shown are representative of three separate experiments.
Two additional studies yielded equivalent results. Band densities of p38 phosphorylation in the Western blots were normalized against p38 (shown
on lower panel). Each bar represents the mean ( SE of the three independent experiments. All means marked with * (P < 0.05) are signiﬁcantly
different from the control. (C) siRNA ASK1 decreased nickel-induced p38 activation. BEAS-2B cells were transfected with 100 nM ASK1 siRNA
and control siRNA, and 24 h later, cells were treated with 2 µg/cm2 Ni3S2 for 48 h. The protein expression was measured by Western Blotting.
ASK1 expression and p38 phosphorylatin were decreased by siRNA ASK1. All results demonstrated here are representatives of three separate
experiments. Band densities of ASK1 and p38 phosphorylation in the Western blots were normalized against actin and p38, respectively (shown
on right panel). Each bar represents the mean ( SE of the three independent experiments. All means marked with * (P < 0.05) are signiﬁcantly
different from the control. (D) SB203580, a p38 MAPK inhibitor, has no effect on ASK1 phosphorylation at Thr838. BEAS-2B cells were pretreated
with or without SB203580 (10 µM) for 2 h and then coincubated with 2 µg/cm2 Ni3S2 for 48 h. The protein levels were measured by Western blot
assays and represented from three separate experiments. Blots were late stripped and reprobed with antibody against ASK1 to ensure equivalent
loading and transfer.
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(15). It is unknown whether activation of ASK1/p38 pathway
by nickel is mediated by Akt.
To obtain direct evidence for the involvement of Akt in
mediating the ASK1/p38 pathway in nickel-induced apoptosis,
we used siRNA that speciﬁcally silences Akt. Both siRNA
control and siRNA Akt products that we used here are from
Cell Signaling Co. and have been tested in-house and shown to
reduce protein expression of Akt. As shown in Figure 4B, both
expression of Akt and phosphorylatd Akt at Ser473 were all
decreased by siRNA speciﬁc to Akt but not the control siRNA.
As compared with siRNA control, protein levels of phospho-
rylated Akt and Akt after siRNA Akt were decreased by almost
70 and 60%, respectively, through quantitative analysis (data
not shown here).
As shown in Figure 4C, activation of ASK1 and downstream
kinase p38 was attenuated by siRNA Akt. In a control
experiment, we transfected BEAS-2B cells with siRNA control
and siRNA Akt. All conditions and procedures are exactly the
same as before except omitting nickel stimulation. Our results
showed that, in the absence of nickel stimulation, siRNA Akt
had no effect on ASK1 phosphorylation at both Thr838 and
Figure 4. Akt is activated and involved in ASK1/p38 MAPK signaling pathway in nickel-induced apoptosis. (A) Nickel induced Akt phosphorylation
at Ser473. BEAS-2B cells were treated with different concentrations of Ni3S2 for 48 h and followed by immunoblot analysis of phospho-Akt at
Ser473. Blots were late stripped and reprobed with antibody against total Akt. The results shown are representative of three separate experiments.
All studies yielded equivalent results. The quantiﬁcation analyses of Akt phosphorylation are shown on lower panel. * (P < 0.05) represents signiﬁcantly
different from the control. (B) Small interfering RNAs designed to target Akt mRNA (Akt siRNA) decreased both Akt phosphorylation at Ser473
and Akt expression. BEAS-2B cells were transfected with 100 nM Akt siRNA and control siRNA for 24 h and then treated with 2 µg/cm2 Ni3S2
for 48 h. The protein expression was measured by Western Blotting. All results demonstrated here are representatives of three separate experiments.
(C) Akt siRNAs attenuated nickel-induced protein phosphorylation of ASK1 and p38 (experimental conditions are the same as in panel B described
above). Blots were late stripped and reprobed with antibody against ASK1 and p38, respectively. Quantiﬁcation of phospho-ASK1 at Thr 838 and
phospho-p38 was normalized to ASK1 and p38, respectively. * (P < 0.05) means signiﬁcantly different from the control, or # (P < 0.05) means
signiﬁcantly different between the indicated two groups. (D) Without nickel stimulation, siRNA Akt has no effect on ASK1 phosphorylation and
p38 phosphorylation. BEAS-2B cells were transfected with 100 nM Akt siRNA and control siRNA, and 72 h later, the protein expression was
measured by Western blotting. All results demonstrated here are representatives of three separate experiments. (E) siRNA Akt attenuates nickel-
induced apoptosis. BEAS-2B cells were transfected with 100 nM Akt siRNA and control siRNA, and 24 h later, cells were treated with 2 µg/cm2
Ni3S2 for 48 h. Apoptosis was measured by ﬂow cytometry as described in the Materials and Methods. Data displayed here are representatives of
three separate experiments. Results shown are the means of triplicate determinations ( S E .*( P < 0.05) means signiﬁcantly different as compared
with the control. # (P < 0.05) represents a signiﬁcant difference between the two indicated groups.
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Blot analysis (Figure 4D). Flow cytometric analysis further
indicated that apoptosis induced by nickel was decreased by
Akt-speciﬁc siRNA (Figure 4E). Accordingly, these observations
demonstrate that Akt plays a role in mediating ASK1/p38
pathway and apoptosis induced by nickel.
Oxidative Stress Involved in the Akt/ASK1/p38 MAPK
Pathway in Nickel-Induced Apoptosis. As signal molecules,
ROS have been implicated in a wide array of apoptotic processes
by mediating signal transduction. Our results have already
demonstrated that nickel could induce ROS generation (Figure
2). Here, to dissect the role of ROS in mediating signal
transduction pathways in nickel-induced apoptosis, BEAS-2B
cells were preincubated with NAC and catalase for 2 h, and
then, the cells were used to study the alteration of signaling
pathway in response to nickel. As shown in Figure 5A-C,
treatment of NAC and catalase attenuated nickel-induced
phosphorylation of Akt, ASK1, and downstream p38 MAPK.
The effects of these ROS modiﬁers on signaling changes are in
agreement with their effects on nickel-induced apoptosis (Figure
2F). Thus, the results show that the generation of ROS
stimulated by nickel is involved in nickel-induced apoptotic
signaling pathway.
Discussion
The present study addressed the importance of ROS in
mediating Akt/ASK1/p38 signal cascades in nickel-induced
apoptosis. Nickel is known to induce genotoxic stress. However,
very limited information is available with regard to the
mechanisms of nickel-induced apoptosis and related signaling
pathways. The nickel-induced apoptosis was ﬁrst reported in
Chinese hamster ovary cells (34). The phenomenon of apoptosis
was also observed in other cell lines, for example, T cell
hybridoma cells, Jurkat cells, and mouse epidermal JB6 cells
(35-37). Fas ligand (FasL) expression, cell cycle alteration,
and activation of c-Myc through the ERK pathway are reportedly
involved in nickel-induced apoptosis (35, 36).
Our study demonstrates that nickel could induce apoptosis
in BEAS-2B cells. Down-regulation of bcl-2 and bcl-xL, two
of the central players of the Bcl-2 family members, was involved
in nickel-induced apoptosis. The Bcl-2 family proteins are the
principal regulators of apoptosis, which consist of two groups,
antiapoptotic members, including Bcl-2, Bcl-xL, Bcl-w, and
Mcl-1, and pro-apoptotic members, including Bax and the BH3-
only families (38). Bcl-2 down-regulation is reportedly involved
in arsenic-induced apoptosis (39). Our study shows that nickel
could down-regulate expression of both bcl-2 and bcl-xL
proteins. Accompanied by apoptosis under stimulation of nickel
is the cell morphological alteration from epithelial cell-like
appearance to becoming elongated and ﬁbroblast-like. This is
in agreement with the observation reported by others (26).
ROS are generated in various biological systems and are well-
known to be important determinants in regulation of cell
signaling pathways involved in proliferation, apoptosis, and
senescence (40, 41). The generation of ROS in response to
certain metals has been implicated in the triggering of apoptosis
(42-44). Nickel compounds have been reported to induce
oxidative damage resulting from an increase of ROS production
(45). Results from the present study demonstrate that nickel
exposure caused ROS production and cell apoptosis. By using
molecular probes CM-H2DCFDA and DHE, we found that
nickel mainly induced H2O2 generation, for no apparent increase
of O2
•- was observed, which is in agreement with the data of
protein expression of catalase and SOD after nickel treatment.
Among antioxidant defense mechanisms in mammalian cells,
Figure 5. Oxidative stress involved in Akt/ASK1/p38 MAPK pathway in nickel-induced apoptosis. (A) Effects of NAC and catalase on the Akt
phosphorylation at Ser473 and ASK1 phosphorylation at Thr838. BEAS-2B cells were pretreated with or without NAC (10 mM) and catalase (2000
units/ml) for 2 h and then coincubated with 2 µg/cm2 Ni3S2 for 48 h. The protein levels were measured by Western blot assays and were from three
separate experiments. Blots were stripped and reprobed with antibody against Akt and ASK1. All conditions are the same as described in Figure
1E. (B) Quantitative analyses of the blots are normalized to Akt and ASK1, respectively. * (P < 0.05) is signiﬁcantly different between the indicated
two groups. (C) Effects of NAC and catalase on p38 phosphorylation. BEAS-2B cells were similarly treated with the agents indicated above, and
p38 phosphorylation was determined by Western blotting. Representatives here are from three separate experiments. Blots were stripped and reprobed
with antibody against p38. Quantitative analyses of the blots are normalized to p38 and displayed on lower panel. * (P < 0.05) represents a
signiﬁcant difference between the two indicated groups.
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key roles in the detoxiﬁcation of H2O2 and O2
•-. Our study
showed that nickel treatment decreased protein expression of
catalase, whereas SOD1 and SOD2 remained unchanged. These
results indicate that H2O2 is likely the main ROS involved in
nickel-induced apoptosis. Moreover, pretreatment of BEAS-2B
cells with NAC, vitamin E, or catalase all reduced nickel-
induced ROS generation, respectively. Even though the exact
mechanism of ROS generation stimulated by nickel is unknown,
several sources of ROS generation could exist in cells, including
cyclooxygenase, lipoxygenase, mitochondrial electron transfer
system, and cytochrome P450. The major source of ROS has
been suggested to be the NADPH oxidase (NOX) (46).
ROS induced by nickel may act as upstream-mediating
molecules of the Akt/ASK1/p38 signaling pathway in nickel-
induced apoptosis in BEAS-2B cells. The Akt kinases play
critical roles in regulating growth, proliferation, survival,
metabolism, and other cellular activities. Akt can phosphorylate
a number of pro-apoptotic proteins, including glycogen synthase
kinase 3 (GSK-3), BAD, caspase 9, and Forkhead transcription
factors, to suppress apoptosis (47-51). A study by others shows
that nickel compounds can activate the Akt pathway to induce
hypoxia-inducible factor transactivation and cap43 expression
(52).
However, in contrast to its well-established survival-promot-
ing role, we found here that Akt also plays a pro-apoptotic role
in nickel-induced apoptosis. The same concentration of nickel
treatment leading to cell apoptosis also induced activation of
Akt. In agreement with our study, recent researches performed
by others also indicate that Akt is not just a single-function
kinase. Under certain conditions, activation of Akt may be
beneﬁcial to cell death. Nogueira et al. showed that Akt
activation increases oxidative stress, which in turn further
increases Akt phosphorylation and renders cells susceptible to
ROS-triggered cell senescence or death (53). Additionally,
anticancer drugs, such as methotrexate, docetaxel, and doxo-
rubicin, can also activate the Akt/CDK2 (cyclin dependent
kinase) pathway to promote, rather than suppress, cell death
(54). Apoptin, a viral protein, has also been reported to
selectively kill cancer cell death through Akt activation followed
by Cdk activation (55). Furthermore, in the case of the death
receptor pathway, activation of Akt by Fas ligand stimulation
leads to apoptosis in epidermal C141 cells (56). Activation of
Akt in nickel-induced apoptosis has also been observed in JB6
cells by another group (37).
Our study demonstrates that nickel induced BEAS-2B cell
apoptosis through the Akt-mediated ASK1/p38 pathway. ASK1
is one of the MAP3K that activates p38 and JNK via activating
the MAP2Ks, MKK4/MKK7 and MKK3/MKK6 (18, 19).
ASK1 is activated by a variety of stresses including calcium
inﬂux, endoplasmic reticulum (ER) stress, lipopolysaccharide
(LPS), ROS, and tumor necrosis factor (57-59). These stresses
induce activation of ASK1 through Thr838 (Thr845 in mice)
phosphorylation (20, 21). In recent years, researches have
revealed that activation of ASK1 plays pivotal roles in a wide
variety of cellular responses, such as cell differentiation,
apoptosis, and immune response, with special focus on oxidative
stress-induced apoptosis (60). Our results show that nickel
treatment induced ASK1 phosphorylation at Thr838, not Ser83,
which decreases ASK1 activity. The results suggest that nickel
induced apoptosis mainly through ASK1 phosphorylation at
Thr838. Activation of ASK1 can selectively activate JNK and
p38 MAP kinases, leading to apoptosis. Here, we found that
nickel treatment caused p38 MAPK phosphorylation, not JNK.
To obtain evidence that ASK1 regulates p38 MAPK, we
employed siRNA method to speciﬁcally down-regulate ASK1
expression. We found that phosphorylation of p38 by nickel
stimulation was attenuated by siRNA ASK1. However, inhibi-
tion of p38 MAPK with pharmacological inhibitor, SB203580,
had no effect on phosphorylation of ASK1 at Thr838, probably
implicating that ASK1 was not reversely regulated by p38
MAPK.
It has been shown that ASK1 activity can be regulated by a
number of ASK1-interacting proteins. Among them, thioredoxin
(Trx) and 14-3-3 can directly bind to ASK1 leading to inhibition
of ASK1 activity (59, 61). Protein phosphatase 5 (PP5) is also
capable of binding to and dephosphorylating Thr838 (Thr845
in mice) to inactivate ASK1 in response to oxidative stress (62).
Previous studies show Akt that can also act as an upstream
kinase of ASK1 to phosphorylate and negatively regulate ASK1
at the site of Ser83 (15-17). Nevertheless, in nickel-induced
apoptosis in BEAS-2B cells, both Akt and ASK1 were all
activated. To elucidate the direct regulation of Akt on ASK1,
we down-regulated Akt by utilizing siRNA speciﬁc to Akt. Our
study shows that under the stimulation of nickel, phosphorylation
of ASK1 at Thr838 and p38 MAPK, downstream of ASK1,
were all attenuated by siRNA Akt. In addition, siRNA Akt also
partially ameliorated nickel-induced apoptosis. On the contrary,
in the absence of nickel stimulation, siRNA Akt showed no
effect on ASK1 phosphorylation at Thr838 and Ser83 as well
as p38 phosphorylation. These observations suggest that Akt
acted upstream of ASK1/p38 MAPK pathway in the nickel-
induced BEAS-2B cell apoptosis. Given the results that we
obtained in siRNA ASK1 (Figure 3C) that p38 phosphorylation
was almost completely inhibited by siRNA ASK1, we propose
that Akt may phosphorylate ASK1 at Thr838 ﬁrst, followed by
p38 phosphorylation. Regulation of p38 activity by Akt through
ASK1 was also demonstrated by others (17, 63). In addition, a
number of substrates have been shown to be downstream of
p38 MAPK activation that are involved in regulating diverse
cellular functions. Among them, the p38/p53 pathway is
reportedly involved in G1-S arrest induced by loss of centrosome
integrity (64). Activation of STAT1 by p38 MAPK has been
shown to be important for LPS-induced death of macrophages
(65). Whether those substrates of p38 MAPK mentioned above
are involved in nickel-induced apoptosis remains to be
investigated.
There is increasing evidence within the literature that ROS
contribute to apoptosis stimulated by diverse stimuli. Our study
also showed that nickel-induced apoptosis was attenuated by
ROS scavenger, indicating that ROS are probably involved in
nickel-induced apoptosis in BEAS-2B cells. Furthermore,
activation of signaling kinases including Akt, ASK1, and
downstream p38 MAPK were all ameliorated by scavenging
ROS, implying that ROS mediated the Akt/ASK1/p38 pathway
in nickel-induced cell apoptosis. Several lines of evidence have
indicated the involvement of ROS in these pathways (66).
For instance, ROS mediate PI3K/Akt signaling and apoptosis
induced by FasL (56). ROS are also required for lipopolysac-
charide (LPS)-induced activation of ASK1/p38 pathway and so
on (57). However, we found that neither NAC nor siRNA Akt
could completely block nickel-induced apoptosis pathway. It
suggests that there are some other factors or pathways contribut-
ing to nickel-induced apoptosis. Apoptosis is a complicated
process. In mammalian cells, there are two major apoptotic
pathways, the death-receptor pathway and the mitochondrial
pathway. In the case of nickel-induced apoptosis, increased FasL
expression, cell cycle alteration, activation of c-Myc through
ROS/Akt/ASK1/p38 Pathway in Nickel-Induced Apoptosis Chem. Res. Toxicol., Vol. 23, No. 3, 2010 575ERK pathway, caspase-8/AIF-mediated pathways, and so on
have been reportedly involved (24, 35-37). Also of note is the
fact that some other unknown pathways are probably also
involved in nickel-induced apoptosis.
In summary, the present study has demonstrated that ROS
induced by nickel probably play a role in nickel-induced
apoptosis. ROS mediates nickel-induced apoptosis through the
Akt-ASK1-p38 axis (Figure 6). Considering the important role
of the Akt signaling pathway in cell transformation and cancer,
understanding the mechanism of nickel-induced apoptosis
through the Akt signaling pathway will be important in
understanding the mechanism of nickel-induced carcinogenesis.
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